Thermogenesis raises $6.67M in a private placement Thermogenesis announced that it has entered into definitive agreements with institutional investors in connection with a private placement of common stock and warrants to purchase common stock. Upon the closing of this financing, ThermoGenesis will receive gross proceeds of approximately $6.67 million resulting from the issuance and sale of approximately 3.33M shares of common stock at a price per share of $2.00. The purchasers will also receive warrants to purchase up to approximately 1.66M shares of common stock at an exercise price of $2.81 per share. The warrants are non-exercisable for six months after the closing of the financing and have a term of 5 years.
Cesca Therapeutics compliant with Nasdaq listing requirements Cesca Therapeutics received a letter from Nasdaq Listings Qualifications indicating that the company complies with Nasdaq listing rules because the company has filed its Forms 10-Q for the periods ended December 31, 2014 and March 31, 2015 with the SEC.